“Pink and Blue” explores the clinical, social, and familial implications of BRCA1 and BRCA2 genetic mutations, which put both women and men at a higher risk of developing numerous cancers.
Without treatment, women who have a BRCA genetic mutation are seven times more likely to develop breast cancer and 30 times more likely to develop ovarian cancer by the age of 70, according to the Centers for Disease Control and Prevention. BRCA mutations may also increase the risk of pancreatic, prostate, and breast cancer among men. Ashkenazi Jews are at a higher risk of possessing BRCA genetic mutations than the general population.
To RSVP for the October 13 film screening, contact Administrative Coordinator Ben Johnston (email@example.com)
In a blog post, Slavitt announced that CMS heard physicians’ concerns about the proposed start date for performance reporting under the new Medicare payment system and that the agency will offer three reporting options for the Merit-based Incentive Payment System (MIPS)—and if you choose one for 2017, you will not receive a negative payment adjustment in 2019.
Financial Health ……………… 302
Building your financial framework as a young physician
Daniel B. Spickard, CLTC
Colleen F. Nolfi
Materia Medica ……………….. 306
Maria A. Felton, PharmD
R. Christopher Durigan, PharmD, BCPS
Legal Summary ………………. 309
Increased access to medication assisted treatment for opioid addiction?
Beth Anne Jackson, Esq.
|Allegheny County Medical
713 Ridge Avenue
Pittsburgh, PA 15212
412-321-5030 FAX 412-321-5323